What is Cannabix Technologies Inc.'s (BLO.CN) StockRank?

MoatMap's StockRank for Cannabix Technologies Inc. (BLO.CN) is 11/100, with a Strong Sell signal. This is a composite score combining Quality (23), Value (19), and Momentum (47) factor ranks across MoatMap's 20,000+ stock universe.

Does Cannabix Technologies Inc. have an economic moat?

Cannabix Technologies Inc. (BLO.CN) has a Quality factor score of 23/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Cannabix Technologies Inc. a buy, hold, or sell?

MoatMap's current signal for Cannabix Technologies Inc. (BLO.CN) is Strong Sell, based on a StockRank of 11/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Cannabix Technologies Inc. in?

Cannabix Technologies Inc. (BLO.CN) operates in the Healthcare sector, specifically the Medical Devices industry (Canada).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

BLO.CN

STRONG SELLREMOVE

Cannabix Technologies Inc. · Healthcare · Canada · $58M · Avg Vol: $18K/d

StockRank

P/E (TTM)

—

ROE

-271.4%

D/E

0.0x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Cannabix Technologies is a micro-cap development-stage company. It is highly speculative, pre-revenue, and lacks any competitive moat or alignment with our core macro themes.

COMPANY DESCRIPTION

Cannabix Technologies Inc. is a medical device company developing innovative breath-testing technologies for the detection of recent cannabis use. The company's proprietary Breath Logalyzer and FAIMS (Field Asymmetric Waveform Ion Mobility Spectrometry) systems target law enforcement, workplaces, and laboratories seeking non-invasive, real-time THC detection. Cannabix holds a strong intellectual property portfolio, positioning it as a pioneer in the emerging drug-impairment testing market.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	0	0	0	0	—
EPS	-0.02	-0.01	-0.02	-0.03	—
Shares	114.1M	114.1M	114.1M	115.4M	+1.1%
Debt	0	93,540	0.1M	0.1M	9.4%
Equity	6.1M	4.7M	3.1M	1.8M	-33.4%
Op CF	-1.5M	-1.4M	-1.5M	-1.3M	—
Inv CF	-3,241	-20,219	-21,849	-12,380	—
Fin CF	0.3M	7,680	-0.1M	-41,264	—

PRICE (1Y)-25.4%

SMA 50SMA 200

$0.37

RSI (14)

29.6

52W High

$0.67

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

-182.2%2.4

ROE

-271.4%2.6

GP/Assets

0.9%12.2

Op. Margin

-1028.2%7.0

FCF/Assets

-71.2%2.8

Piotroski

12.3

Int. Cover

-50.0x6.1

D/E Ratio

0.03x78.0

Current Ratio

6.44x78.3

Value

P/E (TTM)

—N/A

EV/EBITDA

-11.9x25.0

P/FCF

—N/A

P/B

46.2x1.9

P/S

464.0x3.8

Div Yield

—N/A

Momentum

52W High %

56%35.1

RS 6M

-17%62.4

SMA 50/200

1.10x81.5

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$58M

P/E (Forward)

—

Gross Margin

16.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BLO.CN are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
BLO.CN	Cannabix Technologies Inc.(you)	$58M	11	STRONG SELL
TLT.V	Theralase Technologies Inc.	$45M	13	STRONG SELL
PINK.V	Perimeter Medical Imaging AI, Inc.	$30M	9	STRONG SELL
PROF	Profound Medical Corp.	$251M	24	SELL
EDSA	Edesa Biotech, Inc.	$61M	17	STRONG SELL
AIDR.CN	Rocket Doctor AI Inc.	$42M	6	STRONG SELL
ZEN.V	Zentek Ltd.	$50M	1	STRONG SELL
QNTM.CN	Quantum BioPharma Ltd.	$45M	2	STRONG SELL
NVRS.CN	Noveris Health Sciences Inc.	$64M	23	SELL
MSLE	Satellos Bioscience Inc.	$119M	10	STRONG SELL

Peer medians: ROE -42.2% · P/E 14.3x · Gross margin 35.6%

Cannabix Technologies Inc. (BLO.CN) — Stock Score Summary

Cannabix Technologies Inc. (BLO.CN) has a MoatMap StockRank of 11/100 based on Quality (23/100), Value (19/100), and Momentum (47/100) factor scores. The current signal is STRONG SELL. Cannabix Technologies is a micro-cap development-stage company. It is highly speculative, pre-revenue, and lacks any competitive moat or alignment with our core macro themes.

Key Financial Metrics

Price	$0.37
Market Cap	$58M
Price/Book	46.15
Return on Equity	-271.4%
Return on Invested Capital	-182.2%
Debt/Equity	3.27
Gross Margin	16.8%
Operating Margin	-1028.2%
Free Cash Flow	$-2M

Cannabix Technologies Inc. operates in the Medical Devices industry, part of the Healthcare sector (Canada).

Frequently Asked Questions

What is Cannabix Technologies Inc.’s (BLO.CN) StockRank?: MoatMap’s StockRank for Cannabix Technologies Inc. (BLO.CN) is 11/100, with a Strong Sell signal. It is a composite of Quality (23), Value (19), and Momentum (47) factor ranks across MoatMap’s 20,000+ stock universe.
Does Cannabix Technologies Inc. have an economic moat?: Cannabix Technologies Inc. (BLO.CN) has a Quality factor score of 23/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Cannabix Technologies Inc. a buy, hold, or sell?: MoatMap’s current signal for Cannabix Technologies Inc. (BLO.CN) is Strong Sell, based on a StockRank of 11/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Cannabix Technologies Inc. in?: Cannabix Technologies Inc. (BLO.CN) operates in the Healthcare sector, specifically the Medical Devices industry (Canada).